NewsRx

Search our medical news database

Salix Pharmaceuticals, Ltd.

Salix Pharmaceuticals Reports 1Q2007 Results

Published in Healthcare Mergers, Acquisitions and Ventures Week, May 26th, 2007

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced financial and operating results for the first quarter ended March 31, 2007.

Total product revenue was $59.8 million for the first quarter of 2007, a year-over-year increase of 43% compared to $41.9 million for the first quarter of 2006. MOVIPREP(R), OSMOPREP(TM) and VISICOL(R) combined, generated revenue of $11.0 million for the first quarter of 2007. Revenue from these three products, which comprise our bowel cleansing product line, contributed 18% of 1Q07 total product revenue. XIFAXAN(R) revenue for the first quarter of 2007 was $15.4 million, a 134% increase compared to the first quarter of 2006. COLAZAL(R)...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook